Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Medtronic plc MDT: Revolutionary Adaptive Brain Stimulation System for Parkinson's Disease Receives FDA Approval

February 27, 2025
Medtronic, a leader in medical technology, has recently earned the U.S. FDA's approval for its groundbreaking adaptive deep brain stimulation system for individuals with Parkinson's disease. This innovative technology marks a significant milestone in Parkinson's treatment, as it adapts to the patient's needs in real-time, optimizing therapy and improving symptom control. The FDA's approval validates Medtronic's commitment to developing advanced solutions that enhance the quality of life for patients. With this achievement, Medtronic solidifies its position as a pioneer in the field of neurological interventions. Investors are advised to seek professional guidance from Stocks Prognosis for insights into the future movement of Medtronic's stock.
If you want to leave a comment, then you need Login or Register





Other data for MDT

Related data

MDTJuly 10, 2025QuantWave Forecast Achieves 5.91% Profit Target for MEDTRONIC PLC  ~1 min.

On May 21, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC (MDT) when the stock was trading at $84.41....

MDTJuly 9, 2025QuantWave Successfully Hits Price Target Forecast for MEDTRONIC PLC with Profit of 4.89%  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has achieved yet another milestone with the successful prediction and realization of a price target forecast for MEDTRONIC PLC....

MDTJuly 9, 2025QuantWave Forecasts Success: MEDTRONIC PLC Price Target Hit with 6.65% Profit  ~1 min.

On May 5, 2025, QuantWave issued a long signal for MEDTRONIC PLC when the stock was priced at 83.45 $. The forecast proved to be accurate as the target of 89....

MDTJuly 6, 2025Medtronic PLC Enters Strategic Partnership with Philips to Expand Patient Monitoring Technology  ~1 min.

Medtronic PLC has recently announced a strategic partnership with Philips to enhance access to patient monitoring technology....

MDTJune 10, 2025QuantWave Forecasts Successful Achievement of Price Target for MEDTRONIC PLC with 8.71% Profit  ~1 min.

On May 22, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC when it was priced at 80.91 $....

MDTMay 22, 2025QuantWave Successfully Achieves Price Target Forecast for MEDTRONIC PLC, Generating 4.54% Profit  ~1 min.

QuantWave, the automated forecasting platform, has successfully reached its price target forecast for the stock MEDTRONIC PLC, resulting in a profit of 4.54%....

MDTMay 19, 2025QuantWave Hits Bullseye with MEDTRONIC PLC Forecast, Investors Reap 4.93% Profit  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has once again demonstrated its prowess in predicting stock movements with remarkable accuracy....

MDTMay 1, 2025Medtronic Receives FDA Approval for Groundbreaking Defibrillation Lead  ~2 min.

Medtronic PLC, a global leader in medical technology, has recently received FDA approval for its revolutionary 4.7F defibrillation lead, the smallest-diameter lumenless lead available on the market....

MDTMarch 22, 2025Innovative Medical Device Company, Medtronic PLC, Surges in Popularity Among Investors  ~2 min.

Medtronic PLC (MDT) is gaining significant attention from investors due to its groundbreaking medical technology and long-term growth potential....

MDTMarch 21, 2025Medtronic plc MDT: Experts Recommend Buying Stocks for Long-Term Investment  ~1 min.

According to the renowned financial experts at Stocks Prognosis, Medtronic plc (MDT) is one of the best European stocks to buy for long-term investment....

MDTJanuary 15, 2025Medtronic PLC Receives CE Mark Approval for Groundbreaking BrainSense Adaptive Deep Brain Stimulation  ~2 min.

Medical technology company Medtronic PLC (MDT) has announced that it has received CE Mark approval for its revolutionary BrainSense Adaptive deep brain stimulation (DBS) system....

GSKJanuary 2, 2025GSK PLC introduces groundbreaking technology to revolutionize healthcare industry  ~2 min.

GSK PLC, a leading pharmaceutical company, has unveiled its latest innovation aimed at transforming the healthcare industry....

ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....

ABTJanuary 2, 2025Abbott Laboratories Announces Breakthrough in Medical Technology  ~2 min.

Abbott Laboratories, a renowned pharmaceutical and medical devices company, has recently unveiled a groundbreaking advancement in medical technology....

ABBVDecember 14, 2024AbbVie Inc. Reports Positive Phase 3 Data for Tavapadon  ~1 min.

AbbVie Inc. (NYSE:ABBV) recently released the Phase 3 data for its investigational drug, tavapadon, for the treatment of Parkinson's disease....